Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier
The blood-brain barrier (BBB) largely excludes antibodies from entering the central nervous system, thus limiting the potential of therapeutic antibodies to treat conditions such as neurodegenerative diseases and neuro-psychiatric disorders. Here, we demonstrate that the transport of human antibodie...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis Group
2023-12-01
|
| Edice: | mAbs |
| Témata: | |
| On-line přístup: | https://www.tandfonline.com/doi/10.1080/19420862.2023.2229098 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
